CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at the Jefferies 2010 Global Life Sciences Conference at 1:00 p.m. EDT on June 9, 2010, in New York City.
